 |
市场调查报告书
商品编码
1550535
癌症治疗和生物治疗的全球市场：按应用、治疗类型、最终用户和地区分类Global Cancer Therapeutics And Biotherapeutics Market, By Application, By Therapy Type, By Application, By End User, By Geography |
||||||
全球癌症治疗和生物治疗市场规模预计将从 2024 年的 1,941.1 亿美元增至 2031 年的 3,441 亿美元，2024 年至 2031 年复合年增长率为 8.5%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 1941.1亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 8.50% | 2031年价值预测 | 3441亿美元 |
癌症治疗和生物治疗是全球显着成长的市场。虽然化疗等传统治疗方法有其局限性，但新的生物疗法和标靶治疗正在彻底改变癌症治疗。生物疗法利用人体免疫系统的力量，并使用单株抗体和其他药物来抑制癌细胞的生长。标靶治疗专注于癌细胞中发现的特定分子标靶，这与化疗不同，化疗会影响所有快速分裂的正常细胞和癌细胞。随着对癌症生物学认识的进步和技术创新，多种生物製药和标靶治疗已被开发并商业化。这些新的治疗方法正在改善许多癌症患者的存活率和生活品质。
市场动态：
全球癌症治疗和生物治疗市场的成长是由全球癌症发病率上升、对个人化医疗的需求不断增长、癌症药物开发的研究经费增加、新的标靶治疗和生物治疗药物的发布所带来的。然而，开发生物製药和标靶治疗的高成本以及相关的技术挑战正在限制市场成长。增加对新机制和联合治疗的研究和开发为市场扩张提供了机会。
本研究的主要特点
该报告对全球癌症治疗和生物治疗市场进行了详细分析，并介绍了年复合成长率（CAGR%）已发布。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，对全球癌症治疗和生物治疗市场的主要企业进行概况分析。
主要企业包括罗氏、诺华、辉瑞、Astra Zeneca、GlaxoSmithKline Plc和艾伯维。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球癌症治疗和生物治疗市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章 市场动态、法规与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球癌症治疗与生物治疗市场 - 新型冠状病毒（COVID-19）大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球癌症治疗/生物治疗市场：依应用分类（2019-2031）
- 血癌
- 肺癌
- 大肠直肠癌
- 摄护腺癌
- 子宫颈癌
- 头颈癌
- 胶质母细胞瘤
- 恶性脑膜瘤
- 间皮瘤
- 恶性黑色素瘤
- 其他的
第六章全球癌症治疗与生物治疗市场：依治疗类型分类（2019-2031）
- 化疗
- 放射治疗
- 荷尔蒙疗法
- 生物疗法
- 其他的
第七章 全球癌症治疗/生物治疗市场：依最终使用者分类（2019-2031）
- 医院/诊所
- 癌症护理中心
- 研究所
- 其他的
第八章全球癌症治疗与生物治疗市场：按地区（2019-2031）
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
第9章 竞争格局
- 公司简介
- Amgen Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- Hoffmann-La Roche AG
- EnGeneIC Ltd
- Merck &Co Inc.
- Novartis
- Pfizer Inc.
- Johnson &Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Biogen IDEC
- Sanofi
- Novartis AG
- Roche
- Schering-Plough
- Gilead Sciences
- Takeda Pharmaceutical Company
第10章分析师建议
- Wheel of Fortune
- 分析师观点
- Coherent Opportunity Map（COM）
第十一章 参考文献与调查方法
- 参考
- 调查方法
The Global Cancer Therapeutics and Biotherapeutics Market is estimated to be valued at USD 194.11 Bn in 2024 and is expected to reach USD 344.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 194.11 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.50% | 2031 Value Projection: | US$ 344.10 Bn |
Cancer therapeutics and biotherapeutics is a large and growing market globally. While conventional treatment options such as chemotherapy have limitations, newer biological and targeted therapies are revolutionizing cancer treatment. Biological therapies harness the power of the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal and cancerous cells. With advances in understanding cancer biology and technological innovations, a wide range of biologics and targeted therapies are being developed and commercialized. These newer therapeutic approaches have improved survival and quality of life for many cancer patients.
Market Dynamics:
The global cancer therapeutics and biotherapeutics market growth is driven by the rising global cancer burden, growing demand for personalized medicine, increasing research funding for cancer drug development, and launch of novel targeted and biological therapies. However, high developmental costs of biologics and targeted drugs along with associated technical challenges are restraining the market growth. Ongoing R&D for newer mechanisms and combination therapies provide opportunities for market expansion.
Key Features of the Study:
This report provides in-depth analysis of the global cancer therapeutics and biotherapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer therapeutics and biotherapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Roche, Novartis, Pfizer, AstraZeneca, GlaxoSmithKline and AbbVie.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer therapeutics and biotherapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapeutics and biotherapeutics market
Detailed Segmentation-
- By Application
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Breast Cancer
- Cervical Cancer
- Head and Neck Cancer
- Giloblastoma
- Malignant Meningioma
- Mesothelioma
- Melanoma
- Others
- By Therapy Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Radiation Therapy
- Hormone Therapy
- Biotherapy
- Others
- By End User
- Hospitals & Clinics
- Cancer Care Centers
- Research Institutes
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Amgen Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- Hoffmann-La Roche AG
- EnGeneIC Ltd
- Merck & Co Inc.
- Novartis
- Pfizer Inc.
- Johnson & Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Biogen IDEC
- Sanofi
- Novartis AG
- Roche
- Schering-Plough
- Gilead Sciences
- Takeda Pharmaceutical Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Therapy Type
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cancer Therapeutics and Biotherapeutics Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Cancer Therapeutics and Biotherapeutics Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Blood Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cervical Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Head and Neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Giloblastoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Malignant Meningioma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mesothelioma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Cancer Therapeutics and Biotherapeutics Market, By Therapy Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Radiation Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hormone Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Cancer Therapeutics and Biotherapeutics Market, By End-User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cancer Care Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Cancer Therapeutics and Biotherapeutics Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Applications, 2019
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- Hoffmann-La Roche AG
- EnGeneIC Ltd
- Merck & Co Inc.
- Novartis
- Pfizer Inc.
- Johnson & Johnson
- AstraZeneca
- Bristol-Myers Squibb
- Biogen IDEC
- Sanofi
- Novartis AG
- Roche
- Schering-Plough
- Gilead Sciences
- Takeda Pharmaceutical Company
- Amgen Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
滤泡性甲状腺癌药物销售市场 - 全球产业规模、份额、趋势、机会和预测，按类型、最终用户、地区和竞争细分，2019-2029F
癌症治疗和支持治疗药物市场：按癌症类型和药物类别划分－2025年至2030年全球预测
癌症药物市场：按给药途径、治疗类型、类型和最终用户分类 - 全球预测 2025-2030
2024-2032 年按癌症类型、药物类型、配销通路和地区分類的睪丸癌药物市场报告
全球化疗诱导骨髓抑制治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测
癌症治疗药物市场规模、份额、成长分析、按应用、畅销药物、最终用户、地区 - 产业预测，2024-2031
血管生成抑制剂和促进剂市场评估：按产品、应用、最终用户和地区划分的机会和预测（2017-2031）
到 2030 年小分子标靶癌症治疗市场预测：按类型、应用和地区分類的全球分析
全球抗癌药物市场：按应用、治疗方法、最畅销药物、最终用户和地区划分的评估、机会和预测（2016-2030）
到 2030 年全球标靶治疗市场预测：按类型、癌症类型、给药途径、配销通路、最终用户和地区进行分析